Patents by Inventor Roger Michael Eccles

Roger Michael Eccles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide Nucleic Acid Conjugates and Uses Thereof
    Publication number: 20080108545
    Abstract: The invention provides a triphenylphosphonium peptide nucleic acid conjugate. The conjugate comprises a peptide nucleic acid linked via a disulfide bond, to a triphenylphosphonium group. Conjugates of the invention can be used to deliver PNA oligomers across the plasma membrane into cells.
    Type: Application
    Filed: October 15, 2004
    Publication date: May 8, 2008
    Applicant: UNIVERSITY OF OTAGO
    Inventors: Roger Michael Eccles, Aleksandra Filipovska, Robin A.J. Smith, Michael Patrick Murphy
  • Modulation of PAX-2 for controlled apoptosis or survival of cells
    Publication number: 20030092657
    Abstract: The present invention relates to a method of modulating resistance to apoptosis in a patient. The treatment consists of administering to a patient a therapeutically effective amount of an enhancing agent which selectively inhibits or stimulates the function of PAX-2. The enhancing agent of the present invention allows to increase or to reduce resistance to apoptosis depending of targeted cells.
    Type: Application
    Filed: June 19, 2002
    Publication date: May 15, 2003
    Inventors: Paul Goodyer, Roger Michael Eccles, Elena Torban